发明名称 |
INTERACTION BETWEEN HIV NC AND TAT PROTEINS AND THERAPEUTIC TARGET USE FOR LATENCY INHIBITOR THERE OF |
摘要 |
<p>PURPOSE: The interaction of NC and Tat is provided to be able to be effectively used as a therapeutic agent target with a purpose of removing the latent state as the interaction causes the Tat reduction, which acts as one factor causing virus latency. CONSTITUTION: The interaction of HIV NC and Tat is provided as an inhibitor target for hindering the latency, based on that the interaction of HIV NC and Tat protein causes the latency. The amount of Tat is reduced by the interaction of HIV NC and Tat protein so that the transcription of HIV is reduced. The transcription level of HIV is controlled according the expression ratio of Tat.</p> |
申请公布号 |
KR20130094915(A) |
申请公布日期 |
2013.08.27 |
申请号 |
KR20120016176 |
申请日期 |
2012.02.17 |
申请人 |
HANKUK UNIVERSITY OF FOREIGN STUDIES RESEARCH ANDINDUSTRY-UNIVERSITY COOPERATION FOUNDATION |
发明人 |
MYUNG, HEE JOON;HONG, HYE WON |
分类号 |
A61K39/395;A61K38/10;A61K38/16;A61P31/18 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|